Language

News topic

Expected end: 2026-06

All current shortage notices related to Expected end: 2026-06, structured by product, country, active ingredient and reporting period.

11 notices

← All shortages

Belgium

Ropivacaine Fresenius Kabi 10 mg/ml inj. opl. epidur. amp. 5 x 20 ml

Active ingredient: Ropivacaine Hydrochloride

View notice details →
Belgium

Lysotossil 10 mg omh. tabl. 30

Active ingredient: Cloperastine Hydrochloride

View notice details →
Belgium

Cardioaspirine 100 mg maagsapresist. tabl. 84

Active ingredient: Acetylsalicylic Acid

View notice details →
Belgium

Losartan Sandoz 50 mg filmomh. tabl. 98

Active ingredient: Losartan Potassium

View notice details →
Belgium

Caspofungin Sandoz 50 mg inf. opl. (pdr., conc.) i.v. flac. 10 ml

Active ingredient: Caspofungin

View notice details →
Belgium

Tramadol/Paracetamol EG 37.5 mg - 325 mg filmomh. tabl. 100

Active ingredient: Paracetamol; Tramadol Hydrochloride

View notice details →
Belgium

Seroquel XR 400 mg tabl. verl. afgifte 100

Active ingredient: Quetiapine

View notice details →
Belgium

Levobupivacaïne Fresenius Kabi 2.5 mg/ml inj./inf. opl. i.thec./epidur. amp. 5 x 10 ml

Active ingredient: Levobupivacaine

View notice details →
Belgium

Desloratadine Krka 5 mg filmomh. tabl. 30

Active ingredient: Desloratadine

View notice details →

Plan supply. Connect sourcing and warehousing.

For pharmacies, wholesalers and manufacturers: choose the service matching your operational need.